Tilray Stock Up Over 25% in Premarket After Redecan Product Launch

Tilray Brands, Inc. (NASDAQ: TLRY) shares surged dramatically in premarket trading on Friday, December 12, 2025, climbing 27.52% to $10.75 as of 7:21 AM EST. The sharp rise follows the company’s announcement of Redecan’s launch of Amped Live Resin Liquid Diamond vape cartridges, marking a significant expansion in the premium cannabis vape segment.

The stock closed Thursday’s regular session at $8.43, up 2.06%, before the after-hours surge that saw shares jump 31.55% to $11.09. This dramatic price movement positions Tilray for one of its strongest single-day gains in recent months, as investors respond enthusiastically to the company’s strategic product innovation.

New Product Launch Drives Market Enthusiasm

Tilray announced on Thursday that its Redecan Cannabis brand is launching Amped Live Resin Liquid Diamond 1g 510 cartridges, representing the brand’s first entry into the live resin-liquid diamond category.

The debut lineup features two strains: Space Age CK and Blueberry DNTS, which combine 80% Legit Live Resin with 20% Liquid Diamonds to deliver full-spectrum cannabinoids and strain-specific terpenes. Each cartridge is engineered with a TrueDraw Ceramic core made from medical-grade zirconia ceramic and features a wide-body architecture designed to prevent clogs and ensure smooth draws.

The product launch strategically aligns with strong market trends in the Canadian cannabis sector. According to company data, live resin vapes have delivered 6.3% category growth over the past six months, while Liquid Diamond formats remain among the top-selling vape products nationwide.

Vape basket penetration peaks during the winter months of December to February, making the timing of this launch particularly advantageous for capturing increased consumer demand during the holiday season.

Join our Telegram group and never miss a breaking digital asset story.

TLRY Premarket Surge Follows Volatile 2025 Trading

Despite the dramatic premarket surge, Tilray’s stock has faced significant headwinds throughout 2025. The stock is down 36.62% year-to-date and has declined 42.26% over the past month, according to Yahoo Finance data. With a market capitalization of $977.88 million and a 52-week trading range of $3.50 to $23.20, the company’s shares have experienced considerable volatility.

The stock’s recent momentum gained additional support from reports that President Donald Trump may direct federal agencies to reclassify marijuana from Schedule I to Schedule III, though a White House spokesperson indicated no final decisions have been made.

The Amped cartridges are currently available in Ontario and Alberta, with national distribution across Canada scheduled for early 2026 through authorized cannabis retailers. The company’s focus on premium product development and market-timing strategies demonstrates Tilray’s commitment to capturing growth opportunities in the evolving cannabis landscape, even as broader market conditions remain challenging for the sector.

Disclaimer: The author does not hold or have a position in any securities discussed in the article. All stock prices were quoted at the time of writing.